Gene delivery from the E3 region of replicating human adenovirus: evaluation of the 6.7 K/gp19 K region (Q40785400)

23 September 2017

title

Gene delivery from the E3 region of replicating human adenovirus: evaluation of the 6.7 K/gp19 K region (English)

1 reference

23 September 2017

1 reference

Hawkins LK

1

1 reference

23 September 2017

Johnson L

2

1 reference

23 September 2017

Bauzon M

3

1 reference

23 September 2017

Nye JA

4

1 reference

23 September 2017

Castro D

5

1 reference

23 September 2017

Kitzes GA

6

1 reference

23 September 2017

Young MD

7

1 reference

23 September 2017

Holt JK

8

1 reference

23 September 2017

Trown P

9

1 reference

23 September 2017

Hermiston TW

10

1 reference

23 September 2017

publication date

1 August 2001

1 reference

23 September 2017

1 reference

23 September 2017

volume

8

1 reference

23 September 2017

issue

15

1 reference

23 September 2017

page(s)

1123-1131

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301507

23 September 2017

exact match

0 references

cites work

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

Gene delivery from replication-selective viruses: arming guided missiles in the war against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

Generation of adenovirus by transfection of plasmids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

Adenovirus vectors for gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

Gene delivery from the E3 region of replicating human adenovirus: evaluation of the ADP region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

Gene delivery from the E3 region of replicating human adenovirus: evaluation of the E3B region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

Three adenovirus E3 proteins cooperate to evade apoptosis by tumor necrosis factor-related apoptosis-inducing ligand receptor-1 and -2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

The E3-11.6-kDa adenovirus death protein (ADP) is required for efficient cell death: characterization of cells infected with adp mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

Tumor necrosis factor-alpha and Fas activate complementary Fas-associated death domain-dependent pathways that enhance apoptosis induced by gamma-irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

An endotoxin-induced serum factor that causes necrosis of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

Molecular cloning of the complementary DNA for human tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

A phase I trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

Recombinant Human Tumor Necrosis Factor Administered as a 24-Hour Intravenous Infusion. A Phase I and Pharmacologic Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

Tumour immunotherapy using an adenoviral vector expressing a membrane-bound mutant of murine TNF alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

Rapid insertional mutagenesis of DNA by polymerase chain reaction (PCR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

Selective extraction of polyoma DNA from infected mouse cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

Transcriptional Regulatory Sequences of Carcinoembryonic Antigen: Identification and Use with Cytosine Deaminase for Tumor-Specific Gene Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

A 14,500 MW protein is coded by region E3 of group C human adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

Escape from host-antitumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

7 January 2021

Immunologic nonresponsiveness to tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

7 January 2021

Deletion mutants that alter differential RNA processing in the E3 complex transcription unit of adenovirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

7 January 2021

Limb desmoid tumors: a possible role for isolated limb perfusion with tumor necrosis factor-alpha and melphalan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

7 January 2021

Recombinant human tumor necrosis factor-alpha: thrombus formation is a cause of anti-tumor activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

7 January 2021

In vitro remodeling of tumor vascular endothelial cells using conditioned medium from various tumor cells and their sensitivity to TNF-alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

7 January 2021

Identification and gene mapping of a 14,700-molecular-weight protein encoded by region E3 of group C adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301507

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301507

1 reference

Dimensions Publication ID

23 September 2017

1049636162

0 references

1 reference